BioSpace News Archive

The California life Sciences Institutes (CLSI) recently named the winners of the 2019 Amgen Bay Area BioGENEius Challenge. This challenge is a Bay Area competition for high school students that focuses on the students’ individual research projects in the life sciences.Lori Lindburg, president and chief executive officer of CLSI, took time to speak with BioSpace about the organization and the Challenge.

We are highlighting interesting careers in life sciences and we think clinical study coordinator is one of them. Learn more about their job description here.

Here’s a look at six San Francisco Bay Area life science companies that have hit a variety of “best of” lists recently, in no particular order.

The company focuses on developing drugs to treat chronic cough, although their technology may have broader implications for itch, pain and inflammation.

The new initiative against opioids has a goal of reducing related deaths by as much as 40 percent.

Recently published research by MIT neuroscientists indicates that amyloid plaques could be reduced via brain wave stimulation.

Possibly in response to a trend for Medicare-for-All initiatives, healthcare stocks plunged this week. This largely affected companies like UnitedHealth, which fell 3.2%, Anthem, dropping by 6.8%, and Cigna Corp., sliding 5.1%.

Pfizer and Eli Lilly and Company announced top-line results from a Phase III clinical trial of two doses of tanezumab in moderate-to-severe osteoarthritis (OA) of the hip or knee.

Maryland-based United Therapeutics said Sandoz has had eight years to ensure it had its own delivery system in place for its generic pulmonary arterial hypertension medication.

The survey showed that not surprisingly, patients by and large have negative views of the pharma industry when it comes to corporate responsibility and pricing -- mostly pricing.